
    Original Text: EGFR or ALK mutation. Participants with presence of other driver mutations are allowed if targeted therapy is not available as per local standard of care
    Disease/Condition: EGFR Mutation, ALK Mutation, Other Driver Mutation
    Procedure: none
    Drug: none
    Biomarker: none
    Computable Rule: (EGFR Mutation OR ALK Mutation) AND NOT (Other Driver Mutation)

Criterion:
    Patients must have histologically confirmed non-small cell lung cancer (NSCLC), adenocarcinoma subtype, stage IIIA (N2) or IIIB (N3).

Output:
    Original Text: Patients must have histologically confirmed non-small cell lung cancer (NSCLC), adenocarcinoma subtype, stage IIIA (N2) or IIIB (N3).
    Disease/Condition: NSCLC, Adenocarcinoma, Stage IIIA N2, Stage IIIB N3
    Procedure: none
    Drug: none
    Biomarker: none